IBDEI15D ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18624,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,18624,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,18625,0)
 ;;=I35.9^^64^833^74
 ;;^UTILITY(U,$J,358.3,18625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18625,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,18625,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,18625,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,18626,0)
 ;;=I21.4^^64^833^73
 ;;^UTILITY(U,$J,358.3,18626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18626,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,18626,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,18626,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,18627,0)
 ;;=I42.8^^64^833^52
 ;;^UTILITY(U,$J,358.3,18627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18627,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,18627,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,18627,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,18628,0)
 ;;=I20.8^^64^833^9
 ;;^UTILITY(U,$J,358.3,18628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18628,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,18628,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,18628,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,18629,0)
 ;;=I42.2^^64^833^68
 ;;^UTILITY(U,$J,358.3,18629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18629,1,3,0)
 ;;=3^Hypertrophic Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,18629,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,18629,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,18630,0)
 ;;=I35.8^^64^833^75
 ;;^UTILITY(U,$J,358.3,18630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18630,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,18630,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,18630,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,18631,0)
 ;;=I42.5^^64^833^81
 ;;^UTILITY(U,$J,358.3,18631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18631,1,3,0)
 ;;=3^Restrictive Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,18631,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,18631,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,18632,0)
 ;;=I05.8^^64^833^85
 ;;^UTILITY(U,$J,358.3,18632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18632,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,18632,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,18632,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,18633,0)
 ;;=I08.8^^64^833^86
 ;;^UTILITY(U,$J,358.3,18633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18633,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,18633,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,18633,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,18634,0)
 ;;=I47.9^^64^833^79
 ;;^UTILITY(U,$J,358.3,18634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18634,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,18634,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,18634,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,18635,0)
 ;;=I05.1^^64^833^82
 ;;^UTILITY(U,$J,358.3,18635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18635,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,18635,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,18635,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,18636,0)
 ;;=I05.0^^64^833^83
 ;;^UTILITY(U,$J,358.3,18636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18636,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,18636,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,18636,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,18637,0)
 ;;=I05.9^^64^833^84
